CD9, a tetraspanin target for cancer therapy?

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• CD9 protein's dual role as a prognostic marker and predictor of metastatic potential varies by cancer type.
• Understanding CD9's physiological functions and molecular interactions is key to deciphering its role in cancer.
• CD9 is a specific marker for extracellular vesicles involved in intercellular communication.

Purpose of the Study:

• To review the history of CD9 involvement in oncogenesis and cancer metastasis.
• To explore CD9's potential as a tumor-associated antigenic target for cancer therapy.
• To discuss the implications of CD9's role in extracellular vesicles for cancer progression.

Main Methods:

• Literature review of studies on CD9 in cancer.
• Analysis of CD9's physiological functions and molecular partnerships.
• Examination of CD9's association with extracellular vesicles and their role in metastasis.

Main Results:

• CD9 exhibits context-dependent prognostic value in various cancers.
• CD9 is a key component of extracellular vesicles mediating intercellular communication.
• Extracellular vesicles expressing CD9 are implicated in cancer metastasis.

Conclusions:

• CD9's multifaceted roles in cancer warrant further investigation for therapeutic strategies.
• Targeting CD9 or CD9-positive extracellular vesicles may offer novel cancer treatment avenues.
• Further research is needed to overcome limitations and pitfalls in CD9-based cancer therapies.